CEA-Leti heads to CES® to showcase its latest medical technologies
Categorie(s) : Industry, Innovation & Society, News
Published : 7 December 2021
Another two startups founded by CEA-Leti scientists will also be part of the exhibit. Direct Analysis, founded in early 2021, offers a solution that can test for bacteria in food manufacturing plants in just a quarter of the time a conventional test takes. Injectpower, founded in 2020, is commercializing a power source for implants used to monitor eye, brain, and heart conditions.
Also worth noting: CEA-Leti was selected for the January 4 press conference attended by 7,000 international journalists.